In brief
The Trump administration's abrupt halt to the PEPFAR program leaves patients and healthcare providers in despair, as many anticipate a return to critical health crises in Africa.
Sibusiso’s weekly trip to his clinic in Eswatini, a small nation in Southern Africa, brought disturbing news. The facility, where he sought his life-saving HIV medication, was unexpectedly closed. Alongside him, approximately 20 other patients waited outside, bewildered by the locked doors. Once assured of his treatment, Sibusiso, now 39 and out of work, learned that President Trump had temporarily halted funding for the President’s Emergency Plan for AIDS Relief (PEPFAR), a cornerstone of U.S. health aid in Africa valued at $6.5 billion and initiated by former President George W. Bush. This sudden freeze ignited widespread concern among patients, healthcare workers, and public health advocates, reminiscent of earlier crises when HIV was often regarded as a death sentence. With rumors circulating about funding cuts, Sibusiso faced a grim reality. Having just consumed his last dose of antiretroviral medication, he was now left uncertain about how and when to obtain more. He expressed his fears directly, stating, “I’m now thinking of dying. What am I going to do without this treatment?” The Trump administration has indicated that foreign assistance programs would remain paused for three months for a financial review. However, should there be a decision to end PEPFAR entirely, it has been estimated that such a move could lead to approximately 600,000 deaths in South Africa over the next ten years, where the program has the largest patient base according to health studies.
